4.5 Article

Development and Validation of a Risk Score Predicting Risk of Colorectal Cancer

期刊

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
卷 23, 期 11, 页码 2543-2552

出版社

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/1055-9965.EPI-14-0206

关键词

-

资金

  1. National Health and Medical Research Council of Australia [209057, 251533]
  2. German Research Foundation (DFG)
  3. National Health and Medical Research Council of Australia

向作者/读者索取更多资源

Background: Quantifying the risk of colorectal cancer for individuals is likely to be useful for health service provision. Our aim was to develop and externally validate a prediction model to predict 5-year colorectal cancer risk. Methods: We used proportional hazards regression to develop the model based on established personal and lifestyle colorectal cancer risk factors using data from 197,874 individuals from the 45 and Up Study, Australia. We subsequently validated the model using 24,233 participants from the Melbourne Collaborative Cohort Study (MCCS). Results: A total of 1,103 and 224 cases of colorectal cancer were diagnosed in the development and validation sample, respectively. Our model, which includes age, sex, BMI, prevalent diabetes, ever having undergone colorectal cancer screening, smoking, and alcohol intake, exhibited a discriminatory accuracy of 0.73 [95% confidence interval (CI), 0.72-0.75] and 0.70 (95% CI, 0.66-0.73) using the development and validation sample, respectively. Calibration was good for both study samples. Stratified models according to colorectal cancer screening history, that additionally included family history, showed discriminatory accuracies of 0.75 (0.730.76) and 0.70 (0.67-0.72) for unscreened and screened individuals of the development sample, respectively. In the validation sample, discrimination was 0.68 (0.64-0.73) and 0.72 (0.67-0.76), respectively. Conclusion: Our model exhibited adequate predictive performance that was maintained in the external population. Impact: The model may be useful to design more powerful cancer prevention trials. In the group of unscreened individuals, the model may be useful as a preselection tool for population-based screening programs. (C)2014 AACR.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据